Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

Exclusion Criteria

• •Inability to give consent.
• •Prior hormone treatment (i.e., androgen deprivation treatment (ADT) and/or 5-ɑ-reductase inhibitors).
• •Prior PCa treatment.
• •Prior transurethral resection of the prostate (TUR-P) or other prostate surgery.
• •Prior total hip arthroplasty on one or both sides or other metal implants that interfere with the MRI acquisition of the hip region.
• •General contraindications for an MRI scan (i.e., pacemaker, relevant metal implants, etc.).